Literature DB >> 9877223

Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro.

A Pastrakuljic1, R Schwartz, C Simone, L O Derewlany, B Knie, G Koren.   

Abstract

Our objective was to study the characteristics of transfer and biotransformation of nicotine in the human term placenta. Nicotine transfer was studied by dually perfusing an isolated cotyledon of the human placenta in vitro. Nicotine metabolism to cotinine was investigated in intact tissue during perfusion and in placental microsomal fractions. Following the addition of nicotine (40 ng/ml) to the maternal side of the placenta, distribution into placental tissue (0.43 +/- 0.13 ng/ml/min) was three times higher than transfer to the fetal side of the placenta (0.15 +/- 0.01 ng/ml/min). The steady-state maternal-to-fetal transfer of nicotine was approximately 90% that of antipyrine (a marker of flow-dependent transfer). There was no evidence of nicotine metabolism to cotinine by intact placental tissue or in microsomal fractions. The observation that nicotine readily crosses the human placenta with no evidence of metabolism suggests that nicotine has the potential to cause adverse affects on the developing fetus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877223     DOI: 10.1016/s0024-3205(98)00522-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  Changes in maternal and fetal nicotine distribution after maternal administration of monoclonal nicotine-specific antibody to rats.

Authors:  D E Keyler; M G Lesage; M B Dufek; P R Pentel
Journal:  Int Immunopharmacol       Date:  2006-08-04       Impact factor: 4.932

2.  The cholinergic system is involved in regulation of the development of the hematopoietic system.

Authors:  Naira Serobyan; Suchitra Jagannathan; Irina Orlovskaya; Ingrid Schraufstatter; Marina Skok; Jeanne Loring; Sophia Khaldoyanidi
Journal:  Life Sci       Date:  2007-04-29       Impact factor: 5.037

3.  Developmental effects of tobacco smoke exposure during human embryonic stem cell differentiation are mediated through the transforming growth factor-β superfamily member, Nodal.

Authors:  Walter Liszewski; Carissa Ritner; Julian Aurigui; Sharon S Y Wong; Naveed Hussain; Winfried Krueger; Cheryl Oncken; Harold S Bernstein
Journal:  Differentiation       Date:  2012-02-28       Impact factor: 3.880

4.  Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion.

Authors:  Sarah J Hemauer; Svetlana L Patrikeeva; Xiaoming Wang; Doaa R Abdelrahman; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

5.  Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signaling.

Authors:  Virender K Rehan; Reiko Sakurai; Ying Wang; Jamie Santos; Kyle Huynh; John S Torday
Journal:  Lung       Date:  2007 May-Jun       Impact factor: 2.584

6.  Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts.

Authors:  Reiko Sakurai; Laura M Cerny; John S Torday; Virender K Rehan
Journal:  Exp Lung Res       Date:  2010-12-06       Impact factor: 2.459

Review 7.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures.

Authors:  Teresa R Gray; Raquel Magri; Diaa M Shakleya; Marilyn A Huestis
Journal:  Clin Chem       Date:  2008-10-09       Impact factor: 8.327

9.  Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways.

Authors:  Taraneh Taghavi; Christopher A Arger; Sarah H Heil; Stephen T Higgins; Rachel F Tyndale
Journal:  J Pharmacol Exp Ther       Date:  2017-11-20       Impact factor: 4.030

10.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.